Large-scale proteomics across neurological disorders uncovers biomarker panel and targets in multiple sclerosis
Cell · 2026-04 · 189 (7) · 2128-2147.e25
DOI: 10.1016/j.cell.2026.01.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2026-04. Verfasst von Jakob Maximilian Bader und 18 weiteren Autor:innen. Beteiligte Einrichtung: Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany. Hauptthemen laut MEDLINE: Proteomics, Multiple Sclerosis, Biomarkers, Nervous System Diseases. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Federal Ministry of Education and Research Bonn Office, Max Planck Society, German Research Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.
- Department of Neurology, School of Medicine and Health, Klinikum rechts der Isar University Hospital, Technical University of Munich, Munich, Germany.
- Institute of Computational Biology, Helmholtz Center Munich, Munich, Germany.
- NNF Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark; OmicVision Biosciences, Nørrebro, Copenhagen, Denmark.
- Department of Neurology, School of Medicine and Health, Klinikum rechts der Isar University Hospital, Technical University of Munich, Munich, Germany; Institute for Immunity, Transplantation, and Infection, Stanford Uni…
- Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany; School of Engineering and School of Life Sciences, Westlake University, Hangzhou, China.
Förderung
- Federal Ministry of Education and Research Bonn Office
- Max Planck Society
- German Research Foundation
Zitieren
APA
Bader, J. M., Makarov, C., Richter, S., Strauss, M. T., Held, F., Wahle, M., Lorenz, M. B., Pöschl, L., Skowronek, P., Thielert, M., Berthele, A., Zeng, W. F., Ammar, C., Bludau, I., Schubert, B., Theis, F. J., Gasperi, C., Hemmer, B., & Mann, M. (2026). Large-scale proteomics across neurological disorders uncovers biomarker panel and targets in multiple sclerosis. Cell, 189(7), 2128-2147.e25. https://doi.org/10.1016/j.cell.2026.01.017
Vancouver
Bader JM, Makarov C, Richter S, Strauss MT, Held F, Wahle M, et al. Large-scale proteomics across neurological disorders uncovers biomarker panel and targets in multiple sclerosis. Cell. 2026;189(7):2128-2147.e25. doi:10.1016/j.cell.2026.01.017
BibTeX
@article{Bader2026,
author = {Bader, Jakob Maximilian and Makarov, Christine and Richter, Sabrina and Strauss, Maximilian Thomas and Held, Friederike and Wahle, Maria and Lorenz, Michael Baggio and Pöschl, Lara and Skowronek, Patricia and Thielert, Marvin and Berthele, Achim and Zeng, Wen-Feng and Ammar, Constantin and Bludau, Isabell and Schubert, Benjamin and Theis, Fabian J and Gasperi, Christiane and Hemmer, Bernhard and Mann, Matthias},
title = {Large-scale proteomics across neurological disorders uncovers biomarker panel and targets in multiple sclerosis},
journal = {Cell},
year = {2026},
volume = {189},
number = {7},
pages = {2128--2147.e25},
doi = {10.1016/j.cell.2026.01.017}
}
EUVIMED